ICAD INC. - COMMON STOCK

iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28

14 фев 2022 16:05:00 Источник Nasdaq GlobeNewswire

iCAD to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

08 фев 2022 08:00:01 Источник Nasdaq GlobeNewswire

iCAD’s Breast AI Platform Earns U.S. Department of Defense Authorization to Operate

24 янв 2022 14:25:38 Источник Nasdaq GlobeNewswire

iCAD Announces the Appointment of New Members to its Board of Directors

11 янв 2022 08:00:01 Источник Nasdaq GlobeNewswire

iCAD Announces Estimated Q4 and Fiscal Year 2021 Revenues

04 янв 2022 08:00:03 Источник Nasdaq GlobeNewswire

iCAD to Participate at the 11th Annual LifeSci Partners Virtual Corporate Access Event

23 дек 2021 08:00:00 Источник Nasdaq GlobeNewswire

First Recurrent Glioblastoma Tumor is Treated with Xoft Brain IORT in the United States

14 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire

iCAD to Participate at the Imagine AI + Healthcare Investor Summit

06 дек 2021 13:38:56 Источник Nasdaq GlobeNewswire

iCAD Announces CEO Transition

06 дек 2021 08:00:02 Источник Nasdaq GlobeNewswire

iCAD Announces Compelling New and Real-World Data Demonstrating the Value of ProFound AI to be Presented at RSNA 2021

29 ноя 2021 08:00:01 Источник Nasdaq GlobeNewswire

iCAD to Participate in the 12th Annual Craig-Hallum Alpha Select Conference

11 ноя 2021 16:05:01 Источник Nasdaq GlobeNewswire

iCAD to Host 2nd Annual Virtual Investor Webinar on Company’s Innovative Solutions for Cancer Detection and Treatment

11 ноя 2021 08:00:02 Источник Nasdaq GlobeNewswire

iCAD Reports Financial Results for the Quarter Ended September 30, 2021

09 ноя 2021 16:05:01 Источник Nasdaq GlobeNewswire

iCAD to Report Third Quarter 2021 Financial Results on Tuesday, November 9

26 окт 2021 08:00:03 Источник Nasdaq GlobeNewswire

iCAD Unveils Next Generation Technologies at Journées Francophones de Radiologie (October 8-11, Paris, France)

07 окт 2021 08:00:01 Источник Nasdaq GlobeNewswire

iCAD Launches Revolutionary Short-term Personalized Risk Assessment Solution for 3D Mammography

29 сен 2021 08:00:01 Источник Nasdaq GlobeNewswire

iCAD to Host Educational Roundtable to Help Clinicians and Facilities Recover from COVID-19 Impact

09 сен 2021 14:46:04 Источник Nasdaq GlobeNewswire

iCAD’s Xoft Brain IORT Demonstrates Significant Improvement in Overall Survival in Recurrent Glioblastoma According to Comparative Study

31 авг 2021 08:00:01 Источник Nasdaq GlobeNewswire

iCAD Reports Financial Results for the Quarter Ended June 30, 2021

05 авг 2021 16:01:02 Источник Nasdaq GlobeNewswire

iCAD to Participate in the Guggenheim MedTech Disruptors Summit

02 авг 2021 16:05:01 Источник Nasdaq GlobeNewswire